Q32 Bio (QTTB) Short-term Investments (2017 - 2025)

Q32 Bio's Short-term Investments history runs 9 years deep, the most recent figure standing at $19.9 million for Q3 2025.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $19.9 million in Q3 2025; TTM through Sep 2025 was $19.9 million, a N/A change from a year earlier, with the FY2022 full-year figure at $141.0 million, up 196.98% from the prior year.
• Short-term Investments climbed to $19.9 million in Q3 2025 per QTTB's latest filing, from $10.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $157.9 million in Q3 2022 and bottomed at $8.0 million in Q1 2022.
• The 5-year median for Short-term Investments is $62.2 million (2023), against an average of $68.7 million.
• Across the five-year window, Short-term Investments plunged 90.5% in 2022 and surged 1282.31% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $47.5 million in 2021, then jumped by 196.98% to $141.0 million in 2022, then plunged by 47.4% to $74.2 million in 2023, then plunged by 86.54% to $10.0 million in 2024, then jumped by 99.33% to $19.9 million in 2025.
• Per Business Quant, the three latest QTTB Short-term Investments figures stand at $19.9 million (Q3 2025), $10.0 million (Q2 2024), and $19.8 million (Q1 2024).